肝硬化中的肝脑病:治疗方法和发展
Ajay Kumar Mishra1, Radha Krishan Dhiman2
1Department of Hepatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India.
Metabolic brain disease
|May 7, 2025
概括
肝脏脑病 (HE) 管理侧重于降低氨水平. 本综述涵盖了目前和新兴的公开HE治疗方法和预防策略,这些策略对于改善肝硬化患者的生存至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝脑病变 (HE) 是肝硬化的一个常见并发症,显著影响患者的存活率.
- 氨是一种关键的神经毒素,驱动HE的发病,进展和严重程度.
- 多个器官,包括肠道,肌肉,和大脑,都参与氨代谢.
研究的目的:
- 审查当前和试验性药物疗法以及管理公开的HE的程序.
- 讨论HE发作的初级和二级预防的治疗策略.
- 阐明各种抗氨治疗的作用机制.
主要方法:
- 关于高等教育的药物治疗和程序的综合文献综述.
- 分析氨产量减少和消除增强的机制.
- 对HE治疗和预防的单疗法和组合疗法的评估.
主要成果:
- 总结了针对减少和消除氨的既定和新型药物治疗方法.
- 讨论各种器官在氨代谢中的作用和治疗干预点.
- 强调公开的卫生保健治疗和预防策略的重要性.
结论:
- 有效的高温管理需要策略来减少氨产量并增强其清除.
- 单一疗法和组合疗法都显示出治疗明显的HE和预防复发的前景.
- 对新型抗氨剂的进一步研究对于改善肝硬化患者的治疗结果至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
23
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
23
Hepatic Drug Excretion: Enterohepatic Cycling
667
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
667
Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
Enzyme Inhibition
77.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.4K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
Chronic Pancreatitis II: Collaborative Care
46
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
46


